Austria-Parkinson’s Vaccine

  A new inoculation may be the first to stop the debilitating neurological disease by targeting its causes in the brain.Researchers think that most cases of  Parkinson’s develop when a certain protein,called alpha-synuclein,accumulates in the brain and injures and eventually kills nerve cells.The vaccine teaches the immune system to produce antibodies against the protein.The vaccine’s developer AFFiRis,recently started its first human trial to test for safety.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s